Ülke: Almanya Borsa: Frankfurt Sektör: Sağlık Hizmetleri Endüstri: Biyoteknoloji Borsası - Teklifler ve Fiyatlar
Fiyatlar, Piyasa Değerleri, PE ve EPS oranları ile tüm Hisse ve Net Varlıkların Listesi
Almanya (648)
- {{country.name}}
- Tüm ülkeler
- Almanya (648)
Frankfurt (648)
- {{item.name}}
- Tüm borsalar
- Dusseldorf (1)
- Frankfurt (648)
- Munich (27)
- Stuttgart (39)
- XETRA (23)
Sağlık Hizmetleri (648)
- {{item.name}}
- Tüm sektörler
- Sağlık Hizmetleri (648)
Biyoteknoloji (648)
- {{item.name}}
- Tüm Sektörler
- Biyoteknoloji (648)
- İlaç Üreticileri-Genel (45)
- İlaç Üreticileri-Özel ve Genel (277)
- Sağlık Hizmeti Planları (9)
- Tıbbi Bakım Tesisleri (93)
- Farmasötik Perakendeciler (21)
- Sağlık Bilgileri Hizmetleri (81)
- Tıbbi Cihazlar (202)
- Tıbbi Ekipmanlar ve Malzemeler (106)
- Teşhis ve Araştırma (102)
- Medikal Ürün Dağıtımı (22)
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK |
|---|
| Ad Ad | Fiyat Fiyat |
24 sa.% 7g Grafikleri 24 sa.% 7g |
P. Değeri Piyasa değeri | HCM Hacim | 24s düşük | 24s yüksek | Piyasa değeri | F/K Oranı | HBK | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.6 2.84 USD |
+1.94
|
$10.73B 11.73B USD | $230 251.42 USD | $2.6 2.84 USD | $2.6 2.84 USD | $10.73B 11.73B USD | 28.88 | $0.09 0.1 USD | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.4299 0.47 USD |
+0.67
|
$7.86B 8.59B USD | $120K 131.18K USD | $0.4299 0.47 USD | $0.4299 0.47 USD | $7.86B 8.59B USD | 43.28 | $0.01 0.01 USD | |
| BB Biotech AG BBZA.F | $30.75 33.61 USD |
-1.28
|
$1.68B 1.84B USD | $7.02K 7.67K USD | $30.75 33.61 USD | $31.6 34.54 USD | $1.68B 1.84B USD | 12.60 | $2.44 2.67 USD | |
| CureVac N.V. 5CV.F | $3.17 3.46 USD |
+4.07
|
$716.89M 783.66M USD | $42.96K 46.96K USD | $3.02 3.3 USD | $3.27 3.58 USD | $716.89M 783.66M USD | 4.39 | $0.72 0.79 USD | |
| Valneva SE AYJ.F | $2.89 3.15 USD |
-0.48
|
$524.64M 573.5M USD | $1.26K 1.38K USD | $2.89 3.15 USD | $2.92 3.2 USD | $524.64M 573.5M USD | 0 | -$0.08 -0.08 USD | |
| CStone Pharmaceuticals PH4.F | $0.32 0.35 USD |
+1.91
|
$445.91M 487.44M USD | $8.12K 8.87K USD | $0.32 0.35 USD | $0.32 0.35 USD | $445.91M 487.44M USD | 0 | -$0.01 -0.01 USD | |
| Ocugen, Inc. 2H51.F | $0.6099 0.67 USD |
-1.35
|
$179.73M 196.47M USD | $1.34K 1.46K USD | $0.6099 0.67 USD | $0.6099 0.67 USD | $179.73M 196.47M USD | 0 | -$0.18 -0.1 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| Alterity Therapeutics Limited PBN.F | $0.005 0.0054 USD |
+11.11
|
$44.41M 48.55M USD | $150K 163.97K USD | $0.005 0.0054 USD | $0.005 0.0054 USD | $44.41M 48.55M USD | 0 | $0 0 USD | |
| Defence Therapeutics Inc. DTC.F | $0.4699 0.51 USD |
-15.27
|
$25.5M 27.88M USD | $2.75K 3.01K USD | $0.4699 0.51 USD | $0.4699 0.51 USD | $25.5M 27.88M USD | 0 | -$0.06 -0.06 USD | |
| Avecho Biotechnology Limited OEZ.F | $0.0015 0.0016 USD |
0
|
$8.93M 9.76M USD | $45.31K 49.53K USD | $0.0015 0.0016 USD | $0.0015 0.0016 USD | $8.93M 9.76M USD | 0 | $0 0 USD | |
| Active Biotech AB (publ) BTPC.F | $0.0051 0.0055 USD |
-36.25
|
$6.27M 6.86M USD | $32.01K 34.99K USD | $0.0051 0.0055 USD | $0.0051 0.0055 USD | $6.27M 6.86M USD | 0 | -$0.01 -0.01 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.02 0.02 USD |
0
|
$5.56M 6.08M USD | $598 653.69 USD | $0.02 0.02 USD | $0.02 0.02 USD | $5.56M 6.08M USD | 0 | -$0.01 -0.01 USD | |
| Medigene AG MDG1.F | $0.11 0.12 USD |
-26.35
|
$2M 2.19M USD | $40.03K 43.76K USD | $0.08999 0.1 USD | $0.16 0.18 USD | $2M 2.19M USD | 0 | -$1.21 -1.3 USD | |
| BioSenic S.A. BT1.F | $0.0011 0.0012 USD |
0
|
$848.72K 927.77K USD | $500K 546.57K USD | $0.0011 0.0012 USD | $0.0011 0.0012 USD | $848.72K 927.77K USD | 0 | -$0.04 -0.04 USD | |
| Novo Nordisk A/S NOVA.F | $57 62.31 USD |
+4.97
|
$258.64B 282.73B USD | $1.25K 1.36K USD | $54.8 59.9 USD | $57.5 62.86 USD | $258.64B 282.73B USD | 18.81 | $3.03 3.31 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $434.8 475.3 USD |
+0.54
|
$113.14B 123.68B USD | $7 7.65 USD | $434.8 475.3 USD | $434.8 475.3 USD | $113.14B 123.68B USD | 0 | -$1.82 -1.9 USD | |
| CSL Limited CSJ.F | $137.62 150.44 USD |
+0.45
|
$66.84B 73.07B USD | $3 3.28 USD | $137.62 150.44 USD | $137.62 150.44 USD | $66.84B 73.07B USD | 28.61 | $4.81 5.26 USD | |
| CSL Limited CSJA.F | $68 74.33 USD |
0
|
$66.54B 72.74B USD | $6 6.56 USD | $68 74.33 USD | $68 74.33 USD | $66.54B 72.74B USD | 28.33 | $2.4 2.62 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| argenx SE 1AEA.F | $540 590.29 USD |
+1.89
|
$33.33B 36.44B USD | $12 13.12 USD | $540 590.29 USD | $540 590.29 USD | $33.33B 36.44B USD | 47.82 | $11.29 12.34 USD | |
| argenx SE 1AE.F | $539 589.2 USD |
+0.26
|
$32.91B 35.98B USD | $5 5.47 USD | $539 589.2 USD | $539 589.2 USD | $32.91B 35.98B USD | 47.74 | $11.29 12.34 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $221.6 242.24 USD |
-0.63
|
$28.9B 31.59B USD | $37 40.45 USD | $221.6 242.24 USD | $221.6 242.24 USD | $28.9B 31.59B USD | 0 | -$1.92 -2.09 USD | |
| UCB SA UNC.F | $149.95 163.92 USD |
+0.07
|
$28.5B 31.15B USD | $50 54.66 USD | $149.5 163.42 USD | $149.95 163.92 USD | $28.5B 31.15B USD | 27.36 | $5.48 5.99 USD | |
| UCB SA UNC0.F | $73.5 80.35 USD |
0
|
$28.45B 31.1B USD | $50 54.66 USD | $73.5 80.35 USD | $73.5 80.35 USD | $28.45B 31.1B USD | 26.82 | $2.74 3 USD | |
| BeiGene, Ltd. 49B.F | $16.34 17.86 USD |
+1.24
|
$25.18B 27.53B USD | $100 109.31 USD | $16.34 17.86 USD | $16.34 17.86 USD | $25.18B 27.53B USD | 0 | -$0.41 -0.4 USD | |
| BeiGene, Ltd. 49BA.F | $216 236.12 USD |
-1.82
|
$24.42B 26.7B USD | $20 21.86 USD | $212 231.74 USD | $216 236.12 USD | $24.42B 26.7B USD | 0 | -$5.39 -5.8 USD | |
| BioNTech SE 22UA.F | $92.5 101.11 USD |
+1.37
|
$22.34B 24.43B USD | $714 780.5 USD | $91.05 99.53 USD | $93.4 102.1 USD | $22.34B 24.43B USD | 0 | -$2.77 -3.02 USD | |
| Royalty Pharma plc RPD.F | $28.05 30.66 USD |
-0.5
|
$16.39B 17.92B USD | $3 3.28 USD | $28.05 30.66 USD | $28.34 30.98 USD | $16.39B 17.92B USD | 16.69 | $1.68 1.84 USD | |
| United Therapeutics Corporation UTH.F | $259.2 283.34 USD |
+1.37
|
$11.92B 13.03B USD | $10 10.93 USD | $259.2 283.34 USD | $259.2 283.34 USD | $11.92B 13.03B USD | 11.92 | $21.73 23.75 USD | |
| Insmed Incorporated IM8N.F | $61 66.68 USD |
0
|
$11.2B 12.24B USD | $30 32.79 USD | $61 66.68 USD | $61 66.68 USD | $11.2B 12.24B USD | 0 | -$4.91 -5.3 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.15 5.63 USD |
+1.98
|
$10.68B 11.67B USD | $10 10.93 USD | $5.15 5.63 USD | $5.15 5.63 USD | $10.68B 11.67B USD | 27.10 | $0.19 0.21 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $55.04 60.17 USD |
-0.51
|
$10.59B 11.58B USD | $15 16.4 USD | $55.04 60.17 USD | $55.04 60.17 USD | $10.59B 11.58B USD | 28.22 | $1.95 2.13 USD | |
| Incyte Corporation ICY.F | $53.44 58.42 USD |
+3.21
|
$10.48B 11.46B USD | $56 61.22 USD | $52 56.84 USD | $53.44 58.42 USD | $10.48B 11.46B USD | 411.07 | $0.13 0.14 USD | |
| Innovent Biologics, Inc. 6IB.F | $5.95 6.5 USD |
-1.65
|
$9.87B 10.78B USD | $6.56K 7.17K USD | $5.95 6.5 USD | $6.05 6.61 USD | $9.87B 10.78B USD | 0 | -$0.01 -0.01 USD | |
| Exelixis, Inc. EX9.F | $33.42 36.53 USD |
+2.96
|
$9.62B 10.51B USD | $757 827.5 USD | $33.42 36.53 USD | $33.42 36.53 USD | $9.62B 10.51B USD | 21.56 | $1.55 1.69 USD | |
| Moderna, Inc. 0QF.F | $24.33 26.59 USD |
-0.21
|
$9.4B 10.28B USD | $140 153.04 USD | $23.76 25.97 USD | $24.47 26.75 USD | $9.4B 10.28B USD | 0 | -$8.18 -8.9 USD | |
| Verona Pharma plc I9SA.F | $65 71.05 USD |
+15.25
|
$9.31B 10.18B USD | $555 606.69 USD | $62 67.77 USD | $65 71.05 USD | $9.31B 10.18B USD | 0 | -$1.91 -2.08 USD | |
| Akeso, Inc. 4RY.F | $9.7 10.6 USD |
-0.51
|
$8.85B 9.67B USD | $1.8K 1.97K USD | $9.7 10.6 USD | $9.9 10.82 USD | $8.85B 9.67B USD | 0 | -$0.07 -0.07 USD | |
| Ascendis Pharma A/S A71.F | $144 157.41 USD |
+0.7
|
$8.8B 9.62B USD | $50 54.66 USD | $144 157.41 USD | $144 157.41 USD | $8.8B 9.62B USD | 0 | -$6.54 -7.1 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| Revolution Medicines, Inc. 42Z.F | $36.2 39.57 USD |
+4.02
|
$7.07B 7.73B USD | $356 389.16 USD | $36.2 39.57 USD | $36.2 39.57 USD | $7.07B 7.73B USD | 0 | -$3.16 -3.4 USD | |
| Bio-Techne Corporation TE1.F | $43.4 47.44 USD |
-0.46
|
$6.97B 7.62B USD | $176 192.39 USD | $43.4 47.44 USD | $43.4 47.44 USD | $6.97B 7.62B USD | 50.46 | $0.86 0.94 USD | |
| Roivant Sciences Ltd. 87S.F | $9.63 10.53 USD |
+0.29
|
$6.93B 7.57B USD | $600 655.88 USD | $9.63 10.53 USD | $9.71 10.62 USD | $6.93B 7.57B USD | 0 | -$0.88 -0.9 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $299.1 326.96 USD |
+3.32
|
$6.66B 7.28B USD | $99 108.22 USD | $283.8 310.23 USD | $299.1 326.96 USD | $6.66B 7.28B USD | 0 | -$19.3 -21.1 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $53.06 58 USD |
+0.19
|
$6.61B 7.22B USD | $150 163.97 USD | $53.06 58 USD | $53.06 58 USD | $6.61B 7.22B USD | 17.56 | $3.02 3.3 USD | |
| Corcept Therapeutics Incorporated HTD.F | $61.7 67.45 USD |
-0.52
|
$6.6B 7.21B USD | $94 102.75 USD | $61.7 67.45 USD | $61.7 67.45 USD | $6.6B 7.21B USD | 56.60 | $1.09 1.19 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $19.05 20.82 USD |
+0.26
|
$6.52B 7.12B USD | $62 67.77 USD | $19 20.77 USD | $19.05 20.82 USD | $6.52B 7.12B USD | 0 | -$4.34 -4.7 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $102.2 111.72 USD |
+3.48
|
$6.35B 6.94B USD | $420 459.12 USD | $97.84 106.95 USD | $102.2 111.72 USD | $6.35B 6.94B USD | 13.41 | $7.62 8.33 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $31.78 34.74 USD |
+1.44
|
$6.1B 6.67B USD | $300 327.94 USD | $31.25 34.16 USD | $31.78 34.74 USD | $6.1B 6.67B USD | 0 | -$2.54 -2.7 USD | |
| TG Therapeutics, Inc. NKB2.F | $36.46 39.86 USD |
+1.49
|
$5.91B 6.46B USD | $53 57.94 USD | $36.46 39.86 USD | $36.46 39.86 USD | $5.91B 6.46B USD | 280.46 | $0.13 0.14 USD | |
| Legend Biotech Corporation 9LB.F | $30.6 33.45 USD |
+1.32
|
$5.69B 6.22B USD | $135 147.57 USD | $30.2 33.01 USD | $30.8 33.67 USD | $5.69B 6.22B USD | 0 | -$0.85 -0.9 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $53.66 58.66 USD |
+1.05
|
$5.38B 5.89B USD | $100 109.31 USD | $53.66 58.66 USD | $53.66 58.66 USD | $5.38B 5.89B USD | 25.92 | $2.07 2.26 USD | |
| Financière de Tubize SA FTD.F | $117.8 128.77 USD |
0
|
$5.27B 5.76B USD | $70 76.52 USD | $117.8 128.77 USD | $117.8 128.77 USD | $5.27B 5.76B USD | 58.02 | $2.03 2.22 USD | |
| Blueprint Medicines Corporation 2L9.F | $76.42 83.54 USD |
-0.68
|
$5.01B 5.47B USD | $30 32.79 USD | $76.42 83.54 USD | $77.24 84.43 USD | $5.01B 5.47B USD | 0 | -$0.95 -1.03 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $93.42 102.12 USD |
-0.26
|
$4.6B 5.03B USD | $13 14.21 USD | $93.42 102.12 USD | $93.42 102.12 USD | $4.6B 5.03B USD | 0 | -$5.28 -5.7 USD | |
| Cytokinetics, Incorporated KK3A.F | $35.8 39.13 USD |
+0.56
|
$4.36B 4.76B USD | $59 64.49 USD | $35.8 39.13 USD | $35.8 39.13 USD | $4.36B 4.76B USD | 0 | -$4.64 -5.07 USD | |
| Krystal Biotech, Inc. 4KB.F | $148.2 162 USD |
-0.6
|
$4.3B 4.7B USD | $275 300.61 USD | $148.2 162 USD | $148.2 162 USD | $4.3B 4.7B USD | 56.13 | $2.64 2.89 USD | |
| ALK-Abelló A/S 4AJ0.F | $19.3 21.1 USD |
-0.31
|
$4.29B 4.69B USD | $1.2K 1.31K USD | $19.3 21.1 USD | $19.3 21.1 USD | $4.29B 4.69B USD | 39.38 | $0.49 0.54 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $25.93 28.34 USD |
+0.15
|
$4.17B 4.56B USD | $37 40.45 USD | $25.93 28.34 USD | $25.93 28.34 USD | $4.17B 4.56B USD | 0 | -$2.68 -2.9 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Vaxcyte, Inc. 5VA.F | $28.4 31.05 USD |
-0.7
|
$3.71B 4.05B USD | $200 218.63 USD | $28.4 31.05 USD | $28.4 31.05 USD | $3.71B 4.05B USD | 0 | -$3.35 -3.6 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $56 61.22 USD |
0
|
$3.59B 3.92B USD | $11 12.02 USD | $56 61.22 USD | $56.5 61.76 USD | $3.59B 3.92B USD | 0 | -$3.82 -4.1 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $6.25 6.83 USD |
+9.65
|
$3.46B 3.78B USD | $4 4.37 USD | $6.25 6.83 USD | $6.25 6.83 USD | $3.46B 3.78B USD | 18.38 | $0.34 0.37 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| 3SBio Inc. 83B.F | $1.36 1.49 USD |
+3.03
|
$3.28B 3.58B USD | $432 472.23 USD | $1.36 1.49 USD | $1.36 1.49 USD | $3.28B 3.58B USD | 13.59 | $0.1 0.11 USD | |
| Camurus AB (publ) 7CA.F | $53.6 58.59 USD |
+0.66
|
$3.18B 3.47B USD | $30 32.79 USD | $53.6 58.59 USD | $53.6 58.59 USD | $3.18B 3.47B USD | 82.46 | $0.65 0.71 USD | |
| Zai Lab Limited 1ZL.F | $28.2 30.83 USD |
+2.17
|
$3.14B 3.44B USD | $230 251.42 USD | $28.2 30.83 USD | $28.2 30.83 USD | $3.14B 3.44B USD | 0 | -$2.29 -2.5 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $33.2 36.29 USD |
0
|
$3.14B 3.44B USD | $191 208.79 USD | $33.2 36.29 USD | $33.2 36.29 USD | $3.14B 3.44B USD | 0 | -$5.54 -6.05 USD | |
| Akero Therapeutics, Inc. 0K4.F | $36.84 40.27 USD |
+2.96
|
$3.05B 3.33B USD | $125 136.64 USD | $36.84 40.27 USD | $36.84 40.27 USD | $3.05B 3.33B USD | 0 | -$3.31 -3.6 USD | |
| Viking Therapeutics, Inc. 1VT.F | $24.85 27.16 USD |
+11.19
|
$2.86B 3.12B USD | $175 191.3 USD | $22.28 24.35 USD | $24.85 27.16 USD | $2.86B 3.12B USD | 0 | -$1.02 -1.1 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $29 31.7 USD |
+2.84
|
$2.81B 3.07B USD | $60 65.59 USD | $29 31.7 USD | $29 31.7 USD | $2.81B 3.07B USD | 0 | -$3.25 -3.5 USD | |
| Merus N.V. 2GH.F | $32.6 35.64 USD |
0
|
$2.76B 3.02B USD | $300 327.94 USD | $32.6 35.64 USD | $36 39.35 USD | $2.76B 3.02B USD | 0 | -$2.95 -3.2 USD | |
| Genscript Biotech Corporation G51.F | $1.23 1.34 USD |
-0.49
|
$2.73B 2.99B USD | $1K 1.09K USD | $1.23 1.34 USD | $1.23 1.34 USD | $2.73B 2.99B USD | 0 | -$0.07 -0.07 USD | |
| Scholar Rock Holding Corporation 2QK.F | $28.2 30.83 USD |
-0.7
|
$2.68B 2.92B USD | $80 87.45 USD | $27.6 30.17 USD | $28.2 30.83 USD | $2.68B 2.92B USD | 0 | -$2.18 -2.3 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $51 55.75 USD |
-0.2
|
$2.61B 2.86B USD | $29 31.7 USD | $51 55.75 USD | $51 55.75 USD | $2.61B 2.86B USD | 19.10 | $2.67 2.92 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $33 36.07 USD |
+0.61
|
$2.57B 2.81B USD | $11 12.02 USD | $33 36.07 USD | $33 36.07 USD | $2.57B 2.81B USD | 0 | -$2.65 -2.8 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $20.46 22.37 USD |
-2.48
|
$2.5B 2.73B USD | $1.89K 2.06K USD | $20.46 22.37 USD | $20.46 22.37 USD | $2.5B 2.73B USD | 17.63 | $1.16 1.27 USD | |
| Denali Therapeutics Inc. 4DN.F | $14.18 15.5 USD |
+3.92
|
$2.16B 2.36B USD | $50 54.66 USD | $14.18 15.5 USD | $14.18 15.5 USD | $2.16B 2.36B USD | 0 | -$2.27 -2.4 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $12.78 13.97 USD |
-0.16
|
$2.15B 2.35B USD | $2.28K 2.5K USD | $12.78 13.97 USD | $12.78 13.97 USD | $2.15B 2.35B USD | 10.65 | $1.2 1.31 USD | |
| Veracyte, Inc. 12V.F | $27.6 30.17 USD |
-2.13
|
$2.15B 2.35B USD | $32 34.98 USD | $27.6 30.17 USD | $27.6 30.17 USD | $2.15B 2.35B USD | 102.22 | $0.27 0.3 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.14 16.55 USD |
+3.73
|
$2.06B 2.26B USD | $80 87.45 USD | $15.14 16.55 USD | $15.14 16.55 USD | $2.06B 2.26B USD | 0 | -$1.41 -1.5 USD | |
| Amicus Therapeutics, Inc. AM6.F | $6.45 7.05 USD |
+0.78
|
$2.02B 2.21B USD | $73 79.8 USD | $6.45 7.05 USD | $6.45 7.05 USD | $2.02B 2.21B USD | 0 | -$0.16 -0.1 USD | |
| ImmunityBio, Inc. 26CA.F | $2.23 2.43 USD |
-2.79
|
$1.99B 2.17B USD | $1.5K 1.64K USD | $2.22 2.42 USD | $2.28 2.49 USD | $1.99B 2.17B USD | 0 | -$0.55 -0.6 USD | |
| Ascentage Pharma Group International 36X.F | $5.3 5.79 USD |
-3.64
|
$1.88B 2.06B USD | $7K 7.65K USD | $5.3 5.79 USD | $5.35 5.85 USD | $1.88B 2.06B USD | 0 | -$0.16 -0.1 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $93 101.66 USD |
-1.06
|
$1.83B 2B USD | $20 21.86 USD | $93 101.66 USD | $95.5 104.39 USD | $1.83B 2B USD | 0 | -$0.2 -0.2 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $35.6 38.92 USD |
-1.11
|
$1.78B 1.95B USD | $56 61.22 USD | $35 38.26 USD | $35.6 38.92 USD | $1.78B 1.95B USD | 0 | -$1.63 -1.7 USD | |
| Vericel Corporation ATQP.F | $33.4 36.51 USD |
-6.18
|
$1.67B 1.83B USD | $150 163.97 USD | $33.4 36.51 USD | $33.4 36.51 USD | $1.67B 1.83B USD | 185.55 | $0.18 0.2 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $11.78 12.88 USD |
+2.17
|
$1.67B 1.83B USD | $50 54.66 USD | $11.78 12.88 USD | $11.78 12.88 USD | $1.67B 1.83B USD | 0 | -$4.54 -4.9 USD | |
| Everest Medicines Limited 6HN.F | $5.05 5.52 USD |
+1
|
$1.66B 1.82B USD | $50 54.66 USD | $5.05 5.52 USD | $5.05 5.52 USD | $1.66B 1.82B USD | 0 | -$0.39 -0.4 USD | |
| Bavarian Nordic A/S BV3.F | $20.71 22.64 USD |
+2.68
|
$1.64B 1.79B USD | $1.08K 1.18K USD | $20.27 22.16 USD | $20.71 22.64 USD | $1.64B 1.79B USD | 12.25 | $1.69 1.85 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $17.2 18.8 USD |
+4.24
|
$1.59B 1.74B USD | $300 327.94 USD | $17.2 18.8 USD | $17.2 18.8 USD | $1.59B 1.74B USD | 0 | -$2.96 -3.2 USD | |
| Centessa Pharmaceuticals plc 260.F | $11.6 12.68 USD |
-1.69
|
$1.59B 1.74B USD | $0 0 USD | $11.6 12.68 USD | $11.9 13.01 USD | $1.59B 1.74B USD | 0 | -$1.82 -1.9 USD | |
| Galapagos NV GXE.F | $23.7 25.91 USD |
+1.2
|
$1.56B 1.71B USD | $100 109.31 USD | $23.24 25.4 USD | $23.7 25.91 USD | $1.56B 1.71B USD | 0 | -$2.73 -2.9 USD | |
| Galapagos NV GXEA.F | $23.4 25.58 USD |
0
|
$1.54B 1.69B USD | $4 4.37 USD | $23.4 25.58 USD | $23.4 25.58 USD | $1.54B 1.69B USD | 0 | -$2.73 -2.9 USD | |
|
Favori hisse senedi yok.
Henüz favori bir hisse senediniz yok, lütfen burada görmek için favorilere ekleyin |
||||||||||